Correction: Shared germline-biased plasmablast clonotypes shape early neutralizing antibody responses during acute Chikungunya virus infection - Report - MDSpire

Correction: Shared germline-biased plasmablast clonotypes shape early neutralizing antibody responses during acute Chikungunya virus infection

  • By

  • Kritika Dixit

  • Kaustuv Nayak

  • Manpreet Kaur Saini

  • Sofia Qamar

  • Prashant Bajpai

  • Elluri Seetharami Reddy

  • Sahil Ameer

  • Vikas Dhar Dubey

  • Muneeb Pervez

  • Sagar Kohli

  • Kamalvishnu Gottimukkala

  • Shipra Gupta

  • Naushad Khan

  • Deepti Maheshwari

  • Nawaz SM Akhtar

  • Yadya M. Chawla

  • Ramesh Chandra Rai

  • Rohit Sagar

  • Mohammad Islamuddin

  • Wajihul Hasan Khan

  • Nimisha Mishra

  • Ashok Kumar Patel

  • Sujatha Sunil

  • Rakesh Lodha

  • Vineet Jain

  • Pratima Ray

  • Kaja Murali-Krishna

  • Keshav Saini

  • Sanjeev Kumar

  • Anmol Chandele

  • July 2, 2026

  • 0 min

Share

Correction: Influence of Shared Germline-Biased Plasmablast Clonotypes

Overview

This correction addresses an error in the funding statement of the original article regarding the influence of shared germline-biased plasmablast clonotypes on neutralizing antibody responses in chikungunya virus infection. The corrected funding statement clarifies the sources of financial support for the research.

Background

Understanding the immune response to chikungunya virus is critical due to the disease's potential for severe outcomes, particularly in vulnerable populations. Neutralizing antibodies play a key role in controlling viral infections.

Data Highlights

No numerical or trial data is presented in the correction article.

Key Findings

  • The original funding statement contained inaccuracies regarding the sources of financial support.
  • The corrected funding statement specifies the Department of Biotechnology, Ministry of Science and Technology, India, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases.
  • Shared germline-biased plasmablast clonotypes influence early neutralizing antibody responses during chikungunya virus infection.
  • Neutralizing antibody responses are also a focus in related viral infections, such as Zika virus.

Clinical Implications

Accurate funding disclosures are important for maintaining the integrity of scientific research.

Conclusion

This correction highlights the error in the funding statement in the original publication.

Related Resources & Content

  1. Dixit K, Nayak K, et al., Front. Immunol., 2026 -- Correction: Influence of Shared Germline-Biased Plasmablast Clonotypes
  2. Open Forum Infectious Diseases — Zika Virus Neutralizing Antibody Responses Elicited by Vaccination or Infection
  3. The Journal of Infectious Diseases — Neutralizing Antibody Responses to Chlamydia trachomatis in Women and Associations With Chlamydia Outcomes
  4. Frontiers in Immunology — Parenteral neonatal priming followed by heterologous mucosal booster favors IgM+ memory B cell induction over systemic plasma cell differentiation
  5. The Journal of Infectious Diseases — Phase 1 Randomized Double-Blind Study Assessing Safety, Immune Response, and Dosage of Measles-Vectored Vaccine for Chikungunya Virus (MV-CHIK) in Healthy Adults
  6. WHO guidelines for clinical management of arboviral diseases
  7. February 14, 2025 Approval Letter - VIMKUNYA
  8. Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera - PMC

Original Source(s)

Correction: Shared germline-biased plasmablast clonotypes shape early neutralizing antibody responses during acute Chikungunya virus infection

  • by Kritika Dixit, Kaustuv Nayak, Manpreet Kaur Saini, Sofia Qamar, Prashant Bajpai, Elluri Seetharami Reddy, Sahil Ameer, Vikas Dhar Dubey, Muneeb Pervez, Sagar Kohli, Kamalvishnu Gottimukkala, Shipra Gupta, Naushad Khan, Deepti Maheshwari, Nawaz SM Akhtar, Yadya M. Chawla, Ramesh Chandra Rai, Rohit Sagar, Mohammad Islamuddin, Wajihul Hasan Khan, Nimisha Mishra, Ashok Kumar Patel, Sujatha Sunil, Rakesh Lodha, Vineet Jain, Pratima Ray, Kaja Murali-Krishna, Keshav Saini, Sanjeev Kumar, Anmol Chandele

  • July 2, 2026

Related Content

Building a Retina Surgery Program in Sierra Leone

A mission team reflects on surgical innovation, logistical challenges, and the long-term goal of building sustainable vitreoretinal care in West Africa.

CDC leadership continues to try to manufacture a scientific debate on vaccines where none exists

Marburg outbreak is reported in Uganda, threatening to complicate Ebola response in region